Are Online Peptides Safe to Inject? What Lab Tests and FDA Warnings Show

Nobody can tell you that a peptide vial bought online is safe to inject, and the certificate of analysis that came with it cannot either. Peptides sold as "research chemicals" are not made or batch-tested to the standards that apply to injectable medicines. A typical certificate reports one purity figure for one tested sample. It does not show how much peptide your vial holds, whether it is sterile or whether it carries bacterial endotoxin. When researchers have bought and tested online semaglutide and retatrutide, vials held from about half to nearly double the labelled amount.¹²³⁴⁵

This article is for anyone holding such a vial, or about to order one after seeing it promoted on social media. It covers what the paperwork can and cannot tell you, what testing of real online products has found, and which reactions after an injection need a doctor. It gives no dosing information, names no sellers and is not medical advice.

Why injecting raises the stakes

In warning letters sent in March, June and August 2026, FDA told online peptide sellers that "Injectable products are delivered directly into the body, sometimes directly into the bloodstream, and therefore, bypass some of the body's key defenses against toxins and microorganisms that can lead to serious and life-threatening conditions." Each seller labelled its products "research use only" or "not for human consumption"; FDA said evidence from the websites showed the products were "intended to be drugs for human use".¹ Our guide to what "research use only" means covers the legal background.

Approved medicines meet a different standard. US rules require each batch to be tested for "the identity and strength of each active ingredient", require every batch "purporting to be sterile and/or pyrogen-free" to be tested for that, and require sterile processes to be validated.² Even so, FDA says testing "alone is not adequate to ensure quality", because only a small sample of each batch is tested.⁶ An online vial has none of that behind it, which is the core difference between approved and unapproved peptides.

What a certificate of analysis does and does not show

Sellers often post a certificate of analysis with a single HPLC purity figure. Identity, purity, content, sterility and endotoxin are separate tests, each answering a narrow question. The table sets out what each one can and cannot show, based on FDA guidance and published analyses checked on 22 October 2026. The last column reflects FDA's July 2026 review of BPC-157 certificates; certificates for other products may differ.³⁷⁸

Every result applies only to the sample or batch tested, not automatically to your vial, and none of these tests shows that a product is safe in people. You cannot fill the gap by inspecting the vial: FDA says a consumer "usually cannot detect (through smell, touch, or sight)" whether a drug is safe or will work.⁶ Our peptide testing guide explains the methods.

The missing impurity data matters for a reason beyond contamination. Without it, FDA's reviewers said they "cannot rule out the potential for immunogenicity", an unwanted immune reaction to the product.³ For approved drugs this is measured: in Zepbound's trials, 64.5% of people developed antibodies to tirzepatide, with no clinically significant effect on how it worked.¹⁰ Nobody measures it for online products. A laboratory study by Novo Nordisk employees found impurities with immune-triggering potential in compounded and copycat semaglutide.¹¹

What "99% purity" actually means

A "99%" on a certificate is normally an HPLC result: the target peptide's share of what the instrument detects. It is not the share of the powder that is peptide. When researchers bought semaglutide from illegal online pharmacies, the labels claimed at least 99% purity. Each sample showed a single semaglutide signal, yet semaglutide made up only 7.7% to 14.4% of the powder; the authors suspected low-mass impurities their method could not readily identify. They wrote that "research-grade 99% purity and pharmaceutical-grade product quality are distinctly different."⁴ In another study, two peptides made for laboratory research were 20% and 43% undeclared mannitol by weight, which UV detectors do not see.⁹ See peptide purity.

What testing of online products has found

Few laboratories have bought peptide products outside the regulated supply and published what was in them. These are the studies we found in PubMed on 22 October 2026.

Researchers in Hungary and the US ordered semaglutide from illegal online pharmacies selling it without a prescription (Ashraf et al., 2024). Of six orders, three vials arrived and three pens never did. All three vials contained semaglutide, 29% to 39% more than labelled, though semaglutide was only 7.7% to 14.4% of the powder. No living microbes grew, but one vial had raised endotoxin. The team bought only from the cheapest sellers and did not cover social-media sellers.¹²⁴

In Australia, three vials sold as retatrutide were submitted anonymously to a drug-checking service (Piatkowski et al., 2026). All contained retatrutide, at 51%, 165% and 190% of the labelled amount. Metals were well below safety limits; sterility and endotoxin were not tested.⁵

In Belgium, researchers analysed ten of the peptide drugs most often found falsified there, bought from three suspected illegal online pharmacies (Janvier et al., 2018). Amounts varied widely, peptides containing cysteine were 5% to 75% pure, and arsenic and lead were found, one sample at about ten times the limit for injectable medicines. The authors raised concern about chronic toxicity with repeated use.¹³ A separate Belgian report described haemolytic Bacillus cereus bacteria in two illegal injectable peptide drugs.¹⁴

Each study tested only a handful of products, so none shows how common these problems are across sellers. We found no peer-reviewed laboratory survey of BPC-157 or TB-500 products at all. For retatrutide recalls and regulator tests, see our gray-market retatrutide explainer.

Can a sealed vial still be contaminated?

Yes. Contamination happens during manufacture, so an unbroken seal says nothing about what went in. FDA says sterility tests "are limited in their ability to detect contamination because of the small sample size typically used", which is why approved makers must validate how they sterilise and fill products.⁷²

The clearest warning comes from outside the peptide world. In 2012, a steroid injection made by one US compounding pharmacy caused a multistate fungal outbreak; CDC counted 753 cases and 64 deaths. Investigators found fungus in unopened vials. The median patient had received just one injection, and the median time from the last injection to diagnosis was 47 days, with some cases diagnosed up to 249 days later.¹⁵¹⁶ Feeling fine the week after an injection is not proof that the vial was clean.

The reverse problem also exists. The online semaglutide vials tested in 2024 grew no microbes, yet one carried raised endotoxin, which a sterility test does not detect.⁴

If you feel unwell after injecting

Why some people feel sick after a first injection

Several explanations are possible, and they cannot be told apart without testing the product:

• The drug itself. In Zepbound's weight-loss trials, 25% to 29% of people taking the drug reported nausea, against 8% on placebo.¹⁰ Our post on retatrutide side effects covers what the trials of that drug found.
• The wrong amount. Tested vials have held up to 190% of the labelled amount.⁵
• The wrong drug. In Italy and the Netherlands, people who injected "semaglutide" obtained without a prescription were admitted in comas with very low blood sugar; the products contained insulin.¹⁷¹⁸
• Endotoxin. FDA described three patients who developed "low blood pressure, uncontrollable shaking, shivers, and body aches" during or shortly after receiving a compounded injection (NAD+, not a peptide) that was later found to contain excessive bacterial endotoxin.¹⁹
• An allergic reaction. Even approved peptide medicines carry warnings about serious allergic reactions such as anaphylaxis.¹⁰²⁰

Is redness at the injection site normal?

Mild reactions happen with approved injections too. In Zepbound's weight-loss trials, injection-site reactions such as redness, itching, pain or bruising were reported by 6% to 8% of people taking the drug and 2% on placebo; for Wegovy the figures were 1.4% and 1%.¹⁰²⁰

Redness that keeps spreading, warm or swollen skin, pus, red streaks, fever or chills are different. They can be signs of a skin infection such as cellulitis, which needs prompt medical care.²¹ FDA has received a report of "redness, site swelling, pain, and a red lump at the injection site" after a product falsely labelled as compounded tirzepatide.²²

When to get help

Seek urgent care for swelling of the face, lips, tongue or throat, problems breathing or swallowing, fainting or a very rapid heartbeat¹⁰; for shaking, sweating, confusion or seizures, which can signal low blood sugar²³; or for spreading redness with fever.²¹

For anything less urgent, see a doctor, tell them exactly what you injected and where it came from, and keep the vial in case it can be tested. Problems can be reported to FDA MedWatch in the US or to your national regulator.²⁴ Reports matter because harm from these products is largely invisible: FDA says adverse events from compounded GLP-1 drugs are likely underreported, and products bought online are even less visible.²² See also what users report about peptide side effects.

Social media, low prices and "legal to buy"

Many people first meet these products in a short video. The Australian researchers note that retatrutide is marketed to consumers on social media using claims that "cannot be independently verified".⁵ In a 2026 review of 194 popular TikTok and YouTube Shorts videos on GLP-1-type drugs, obesity specialists found most carried no accurate clinical information; promotion of compounded products was about four times as common on TikTok.²⁵ Some of the review's authors reported ties to drug makers. Our guide on how to verify peptide claims on social media shows how to check what you see.

We found no published cost analysis of why online peptides are cheaper. But the sellers FDA warned had no approved application, while approved makers must test every batch and validate sterile processes.¹² The semaglutide study's authors suggested that purification steps, which are "time-consuming and costly", may have been skipped.⁴ FDA lists prices "that seem too good to be true" as a red flag.²²

Being able to buy something is not evidence that it is safe to inject, and route matters. FDA's concern about GHK-Cu applies specifically to "compounded injectable drugs containing GHK-Cu", which "may pose risk for immunogenicity", and it lists similar concerns for BPC-157 and other peptides.²⁶ Most unapproved peptides have no long-term human studies; FDA did not identify any carcinogenicity studies of BPC-157.³ Even lawfully compounded drugs "are not FDA approved", so FDA does not review them for safety or quality before sale.²² We explain why anyone can buy BPC-157 online and the HHS peptide plan separately.

Safer routes to a peptide medicine

If what you want is an approved peptide medicine, FDA advises getting a prescription from your doctor and filling it at a state-licensed pharmacy; its BeSafeRx pages explain how to check an online pharmacy.²² FDA also says compounded drugs should only be used when an approved drug cannot meet a patient's needs.²² For experimental peptides, a clinical trial is the regulated route; see how clinical trials work and how to join a weight-loss drug trial.

Having a clinician give the injection does not fix the contents of a vial. A clinician can prescribe an approved product and treat a reaction quickly, but the endotoxin reactions FDA described happened in patients whose healthcare provider then reported them.¹⁹